🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

A. Chan

Moffitt Cancer Center

ORCID: 0000-0001-6913-6764
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: 1423 POSTER Polymorphism Analysis in the AVADO Randomised Phase III Trial of First-line Bevacizumab (BEV) Combined With Docetaxel in HER2-negative Metastatic Breast Cancer (mBC).

32 citations

A. Chan, J. Zhu, E. Schönbrunn, Rezaul M. Karim

23 citations

Huda Zahid, A. Chan, Noelle M. Olson, Jorden A. Johnson, Siva Talluri +3 more

35 citations

Caroline R. Buchholz, Manjulata Singh, Michael F. Ciccone, A. Chan, Stanley Nithianantham +8 more

8 citations

Sam Schulman, John M. Kittelson, Thomas C. Abshire, James F. Casella, Rita Dale +78 more

N/A
0DataRank · unranked
2 citations

Taimeng Liang, Jonathan Solberg, A. Chan, Prakriti Kalra, Rui Shi +5 more